Latest Trials

EudraCT Number: 2005-001499-10 Sponsor Protocol Number: CO34 Start Date: 2005-05-19
Sponsor Name: Dr. José Ramón Mel Lorenzo
Full Title: 'Pilot trial of Pegilated Liposomal Doxorrubicin (Caelyx) in combination with Docetaxel (Taxotere) in advanced breast cancer patients' Estudio Piloto de Doxorrubicina Liposomal Pegilada (Caelyx) en...
Medical condition: Advanced Breast Cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-000934-19 Sponsor Protocol Number: 2005-130 Start Date: 2005-05-19
Sponsor Name: Neurologisk Afdeling Århus Universitetshospital
Full Title: Undersøgelse af subcutan immunglobulin behandling af patienter med multifokal motorisk neuropati
Medical condition: Multifokal motor neuropathy
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004169-13 Sponsor Protocol Number: 1 Start Date: 2005-05-19
Sponsor Name: south manchester university hospital nhs trust
Full Title: A Pilot study to assess the effects of beta-blockade on exercise capacity and BNP levels in patients with predominantly diastolic heart failure
Medical condition: Diastolic heart failure
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-004533-34 Sponsor Protocol Number: BIOV-221 Start Date: 2005-05-19
Sponsor Name: Bioenvision
Full Title: A Phase IV Non-randomised Study of Modrenal® (Trilostane) in Post-menopausal Women with Advanced, Oestrogen Receptor Positive Breast Cancer for whom Prior Endocrine Therapies have Failed, One of w...
Medical condition: Advanced, Oestrogen Receptor Positive Breast Cancer for whom Prior Endocrine Therapies have Failed, One of which was an Aromatase Inhibitor
Disease: Version SOC Term Classification Code Term Level
7.0 10057654 LLT
Population Age: Adults Gender: Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-005244-28 Sponsor Protocol Number: GPOH-HD 2002 Pilot / VECOPA Start Date: 2005-05-19
Sponsor Name: Universität Leipzig
Full Title: Pilotstudie zur Therapieoptimierungsstudie für den Morbus Hodgkin bei Kindern und Jugendlichen Prüfung der Verträglichkeit der Chemotherapiekombination VECOPA bei Patienten der Therapiegruppen 2 ...
Medical condition: Pilotstudie zur Therapieoptimierungsstudie für den Morbus Hodgkin bei Kindern und Jugendlichen Prüfung der Verträglichkeit der Chemotherapiekombination VECOPA bei Patienten der Therapiegruppen 2 ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2004-001937-40 Sponsor Protocol Number: EORTC 16032-18031 Start Date: 2005-05-19
Sponsor Name: European Organisation for Research and Treatment of Cancer
Full Title: Randomized, open phase II study of immunization with the recombinant MAGE-3 protein combined with adjuvant AS02B or AS15 in patients with unresectable and progressive metastatic cutaneous melanoma
Medical condition: Unresectable and progressive metastatic cutaneous melanoma
Disease: Version SOC Term Classification Code Term Level
7.0 10027155 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing) IT (Completed)
Trial results: View results
EudraCT Number: 2005-001614-41 Sponsor Protocol Number: CSTI571BIT06 Start Date: 2005-05-19
Sponsor Name: NOVARTIS FARMA
Full Title: OPEN-LABEL TRIAL OF GLIVEC IMATINIB MESYLATE IN PATIENTS WITH REFRACTORY DESMOPLASTIC SMALL ROUND CELL TUMORS DSRCT EXPRESSING A MOLECULAR TARGET OF GLIVEC PDGF-R AND/OR C-KIT
Medical condition: TREATMENT OF PATIENTS WITH REFRACTORY DESMOPLASTIC SMALL ROUND CELL TUMORS DSRCT .
Disease: Version SOC Term Classification Code Term Level
6.1 10039491 PT
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-004042-41 Sponsor Protocol Number: D5890C00003 Start Date: 2005-05-18
Sponsor Name: AstraZeneca AB
Full Title: A comparison of the inflammatory control of asthma provided by one inhalation of Symbicort® Turbuhaler® 160/4.5 µg/inhalation b.i.d. plus as-needed versus one inhalation of Symbicort® Turbuhaler® 3...
Medical condition: This is a Phase IIIB trial to be conducted in adult asthmatic patients.
Disease: Version SOC Term Classification Code Term Level
10003553
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed) SE (Completed) GB (Completed) ES (Completed) DK (Completed)
Trial results: View results
EudraCT Number: 2005-000897-38 Sponsor Protocol Number: DAM/001/05 Start Date: 2005-05-18
Sponsor Name: FARMACEUTICI DAMOR
Full Title: Open-label, controlled, randomised, multicentre, parallel group clinical trial of efficacy and tolerability of Fitostimoline soaked gauzes, Fitostimoline cream and Citrizan gel in the topical...
Medical condition: Topical treatment of second-degree superficial cutaneous burns
Disease: Version SOC Term Classification Code Term Level
6.1 10006802 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-003975-35 Sponsor Protocol Number: 750201.01.014 Start Date: 2005-05-18
Sponsor Name: Dr. Willmar Schwabe GmbH & Co. KG
Full Title: Multi-center, double-blind, placebo-controlled, randomized phase III study to prove the efficacy, safety and tolerability of Lavender oil WS 1265 (Lavandula angustifolia) in patients with restlessn...
Medical condition: restlessness and sleep disturbances MedDRA Code for RESTLESSNESS: 10038743 MedDRA Code für SLEEP DISTURBANCES: 10040997
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe